Twitter | Search | |
Search Refresh
Dr. Britt Baker, D.M.D. Apr 8
The face of ’s women’s division.
Reply Retweet Like
Dr. Britt Baker, D.M.D. Apr 15
Yes I’ll allow it
Reply Retweet Like
SY Investing Jun 18
Sarepta & Selecta entered into a Research License and Option agreement granting Sarepta an option to license the rights to Selecta’s immune tolerance platform, ImmTOR™, for use in AAV gene therapies for & LGMDs. Financials undisclosed.
Reply Retweet Like
SY Investing Jul 2
Hansa granted Sarepta exclusive license to develop and promote imlifidase as a potential pre-treatment prior to the administration of in & patients with NAbs to AAV. Sarepta to pay $10M u/f + up to $397.5M milestones.
Reply Retweet Like
Dr. Britt Baker, D.M.D. Jul 6
Hope you’re loving the flowers I’m growing with all the dirt you’ve been throwing on my name. Still the face of the women’s division. 💐😘
Reply Retweet Like
CdnAssocOfPompe Jul 27
Reply Retweet Like
Zoe Davidson Jun 8
Updated systematic review on the global prevalence of . Pooled global DMD prevalence was 7.1 cases/100,000 males and 2.8 cases/100,000 in the general population.
Reply Retweet Like
#SCLUSIVE💥 Jul 29
- Studio later today; I can’t wait 🤩🥁!!
Reply Retweet Like
Z ♡'s @eboys420 & @onedirection & @brendonurie Apr 27
Replying to @jalboyhcult
Reply Retweet Like
joinourboys Jun 25
5 Years Ago Today...💔 Sadly the boys are now in wheelchairs and are not running around as you see them in this video. We MUST end Duchenne and all of the heartbreak it brings💔.
Reply Retweet Like
Dyne Therapeutics Jul 20
Today we welcomed Francesco Muntoni to our Scientific Advisory Board. Dr. Muntoni’s research group led the development of the first genetic therapies for , and he continues to drive cutting-edge clinical research of neuromuscular diseases. See more:
Reply Retweet Like
Ed Holton May 14
Tutorial on why and how silage should be cut on the 13th of May for quality
Reply Retweet Like
첸둥이 ll KimKukwa 🌼 💖 Jun 22
Just finished plucking some ripe chenvocado from our garden 🤣🥑💕✨ . . . . .
Reply Retweet Like
Terri Ellsworth Jul 20
I’m very honored to have been nominated for a WEGO Health Award in the category of ADVOCATING FOR ANOTHER. I’d be honored to have your vote and endorsement. Thanks in advance!
Reply Retweet Like
Woodsy Feb 16
The advantage of 1st of it's kind PoL contract over the ageing PoS!!!! Our time is near 🔥
Reply Retweet Like
U of T Mississauga May 31
Max’s Big Ride hits the road: Supporters invited to ride at home in support of the annual fundraiser for Duchenne muscular dystrophy research via Inside Halton. Read more:
Reply Retweet Like
Zoe Davidson Jun 8
An excellent review examining the safety of in
Reply Retweet Like
BioCentury Jan 22
Disparities in FDA decisions on Sarepta DMD therapy Vyondys raise questions about integrity of review process
Reply Retweet Like
ORDIndia Feb 29
Reply Retweet Like
Capricor Jun 15
UC Davis Health’s Story on Capricor’s HOPE-2 Clinical Trial in Duchenne Muscular Dystrophy >>>Click the link to read full article>>>
Reply Retweet Like